Keyword: Intellect Neurosciences
News
03.05.2013
- A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, the second time he has run afoul of U.S. securities...
News
30.09.2011
- ViroPharma announced the license of worldwide rights from Intellect Neurosciences to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's...